Scientific article
Open access

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

ContributorsJarlborg, Matthias; Courvoisier, Delphine; Lamacchia, Céline; Martinez Prat, Laura; Mahler, Michael; Bentow, Chelsea; Finckh, Axel; Gabay, Cem; Nissen, Michaël; physicians of the Swiss Clinical Quality Management (SCQM) registry
Published inArthritis Research and Therapy, vol. 22, no. 1, 105
Publication date2020

Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (DAMP) protein and reflects mainly neutrophil activation. Serum calprotectin levels might be a good alternative to acute-phase protein as a biomarker in inflammatory rheumatic diseases. The aim of this study is to investigate the association of serum calprotectin with disease activity and severity in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA).

Citation (ISO format)
JARLBORG, Matthias et al. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. In: Arthritis Research and Therapy, 2020, vol. 22, n° 1, p. 105. doi: 10.1186/s13075-020-02190-3
Main files (1)
Article (Published version)
Secondary files (1)
ISSN of the journal1478-6354

Technical informations

Creation12/10/2020 1:48:00 PM
First validation12/10/2020 1:48:00 PM
Update time03/16/2023 12:18:16 AM
Status update03/16/2023 12:18:15 AM
Last indexation02/12/2024 12:03:45 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack